Literature DB >> 4143624

Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer.

P G Scheurlen, W Schneider, A Pappas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4143624     DOI: 10.1016/s0140-6736(71)90586-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  E-rosette inhibiting substance in Hodgkin's disease spleen extracts.

Authors:  M M Bieber; Z Fuks; H S Kaplan
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

2.  The effect of quadruple chemotherapy on the peripheral blood lymphocyte populations in Hodgkin's disease.

Authors:  A Clay; A Swain; J R Trounce
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

3.  Metabolism of immunoglobulin A, lymphocyte function, and histocompatibility antigens in patients on anticonvulsants.

Authors:  R A Shakir; P O Behan; H Dick; D G Lambie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-04       Impact factor: 10.154

4.  Inhibition of normal lymphocyte transformation by plasma and lymphocyte factors in chronic lymphatic leukaemia.

Authors:  H B Tavadia; R B Goudie; W D Nicoll
Journal:  Clin Exp Immunol       Date:  1974-02       Impact factor: 4.330

5.  Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors.

Authors:  R N MacSween; M A Thomas
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

6.  [Immunopathology in Hodgkin's disease].

Authors:  P G Scheurlen
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

7.  The response to phytohaemagglutinin (PHA) of lymphocytes from cancer patients.

Authors:  S Kumar; G Taylor
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

8.  Purification and properties of a lymphocyte inhibition factor from human serum.

Authors:  W H Ford; E A Caspary; B Shenton
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

9.  Reduced lymphocyte transformation in early cancer of the breast.

Authors:  L A Knight; W M Davidson
Journal:  J Clin Pathol       Date:  1975-05       Impact factor: 3.411

10.  Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease.

Authors:  H Rühl; W Vogt; G Bochert; S Schmidt; H Schaoua; R Moelle
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.